Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LTR Pharma Limited ( (AU:LTP) ) has provided an update.
LTR Pharma Limited has applied for quotation on the ASX of 50,000 additional ordinary fully paid shares under its existing ticker LTP. The new securities, issued on 9 February 2026, modestly increase the company’s free float and available tradable equity, offering a slightly larger base for investor participation without materially altering its capital structure.
More about LTR Pharma Limited
LTR Pharma Limited is an Australian pharmaceutical company listed on the ASX under the code LTP. The company operates in the life sciences sector, with its ordinary fully paid shares traded on the Australian Securities Exchange, providing investors access to its capital and growth prospects.
Average Trading Volume: 296,605
Technical Sentiment Signal: Sell
Current Market Cap: A$89.05M
Find detailed analytics on LTP stock on TipRanks’ Stock Analysis page.